Retirement Systems of Alabama Purchases 39,223 Shares of The Cooper Companies, Inc. $COO

Retirement Systems of Alabama boosted its position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 95.7% during the 3rd quarter, HoldingsChannel reports. The firm owned 80,210 shares of the medical device company’s stock after buying an additional 39,223 shares during the quarter. Retirement Systems of Alabama’s holdings in Cooper Companies were worth $4,534,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in COO. BlackRock Inc. acquired a new stake in Cooper Companies in the 2nd quarter valued at approximately $1,077,762,000. Generation Investment Management LLP bought a new stake in shares of Cooper Companies during the second quarter valued at about $356,304,000. Jupiter Topco LLC bought a new stake in shares of Cooper Companies during the second quarter valued at about $305,074,000. JANA Partners Management LP grew its position in Cooper Companies by 0.5% in the 2nd quarter. JANA Partners Management LP now owns 3,582,480 shares of the medical device company’s stock valued at $256,900,000 after buying an additional 17,322 shares in the last quarter. Finally, Wellington Management Group LLP grew its position in Cooper Companies by 3.1% in the 2nd quarter. Wellington Management Group LLP now owns 3,468,951 shares of the medical device company’s stock valued at $248,758,000 after buying an additional 103,044 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Insider Activity at Cooper Companies

In other Cooper Companies news, Director Lawrence Kurzius acquired 10,000 shares of the firm’s stock in a transaction on Monday, September 14th. The stock was purchased at an average cost of $53.91 per share, for a total transaction of $539,100.00. Following the transaction, the director owned 21,099 shares of the company’s stock, valued at $1,137,447.09. The trade was a 90.10% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Walter Rosebrough, Jr. acquired 7,000 shares of Cooper Companies stock in a transaction that occurred on Friday, September 11th. The shares were purchased at an average cost of $54.11 per share, with a total value of $378,770.00. Following the transaction, the director owned 17,000 shares of the company’s stock, valued at approximately $919,870. The trade was a 70.00% increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have acquired 34,701 shares of company stock valued at $1,880,039. Company insiders own 2.08% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $62.65 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.73 and a current ratio of 1.22. The company has a market cap of $11.91 billion, a PE ratio of 21.38, a price-to-earnings-growth ratio of 2.46 and a beta of 0.83. The Cooper Companies, Inc. has a 52 week low of $51.01 and a 52 week high of $89.83. The firm has a 50 day simple moving average of $58.49 and a 200 day simple moving average of $68.15.

Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same quarter last year, the business posted $0.49 EPS. The company’s revenue was up .5% on a year-over-year basis. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, research analysts expect that The Cooper Companies, Inc. will post 4.53 earnings per share for the current year.

Cooper Companies announced that its board has authorized a stock buyback program on Wednesday, September 9th that authorizes the company to repurchase $3 billion in shares. This repurchase authorization authorizes the medical device company to buy up to 22.7% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s management believes its shares are undervalued.

Trending Headlines about Cooper Companies

Investors following COO have been watching these headlines:

  • Positive Sentiment: A recent article highlights Cooper’s relatively high cash yield, suggesting investors may be overlooking a potential source of value. The supplied information does not include the article’s supporting figures or analysis. Why Is Everyone Ignoring Cooper Companies Stock’s High Cash Yield?
  • Negative Sentiment: Rosen Law Firm says it is investigating potential securities claims tied to allegations that Cooper may have provided materially misleading business information. The notices encourage affected investors to contact the firm; they do not establish wrongdoing or indicate that a claim has been proven. The investigation could nevertheless weigh on sentiment and raise concerns about potential legal costs or reputational impact. Rosen investigation notice Rosen investor notice

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Wells Fargo & Company set a $61.00 price objective on shares of Cooper Companies and gave the company an “equal weight” rating in a report on Thursday, September 10th. Barclays raised Cooper Companies to a “hold” rating in a research note on Wednesday, October 7th. UBS Group decreased their target price on Cooper Companies from $75.00 to $66.00 and set a “neutral” rating for the company in a research note on Thursday, September 10th. Citigroup reaffirmed a “neutral” rating and issued a $60.00 price objective (down from $80.00) on shares of Cooper Companies in a research note on Thursday, September 10th. Finally, Zacks Research cut Cooper Companies from a “hold” rating to a “strong sell” rating in a report on Friday, September 11th. Four research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $68.60.

View Our Latest Stock Analysis on COO

About Cooper Companies

(Free Report)

CooperCompanies is a global medical device company focused on vision care and women’s health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women’s health and fertility care.

Featured Articles

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.